Skip to main content
BFRG
NASDAQ Life Sciences

BullFrog AI Flags Going Concern Doubt and Nasdaq Bid Price Deficiency

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.589
Mkt Cap
$10.535M
52W Low
$0.425
52W High
$2.04
52W Position info
39% above low
Off High info
71% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

BFRG sits 39% above its 52-week low of $0.425.

Summary

BullFrog AI's Q2 10-Q discloses a going concern warning and failure to meet Nasdaq's minimum bid price requirement, with limited financing capacity remaining.


Key Events · Earnings and Guidance · BFRG

  • Going Concern Warning

    Cash of $7.0 million is insufficient to fund planned operations for at least a year beyond the filing date, raising substantial doubt about the company's ability to continue as a going concern.

  • Nasdaq Bid Price Deficiency

    The company failed to regain compliance with the $1.00 minimum bid price by August 10, 2026, and requested a 180-day extension on July 30, 2026. A reverse stock split is under consideration.

  • Financing Capacity Constrained

    ATM capacity is limited to approximately $0.6 million due to public float restrictions, while the ELOC facility has $4.1 million remaining. Total available financing is $4.7 million.

  • Revenue from Feasibility Agreement

    Recognized $215,385 in collaboration revenue from a global pharmaceutical client for the first deliverable under a feasibility agreement signed in March 2026.


Analysis · BFRG · Life Sciences

The 10-Q reveals that cash of $7.0 million is insufficient to fund operations for at least a year, raising substantial doubt about the company's ability to continue as a going concern. Additionally, the company failed to regain compliance with Nasdaq's $1.00 minimum bid price by the August 10, 2026 deadline and has requested a 180-day extension. With ATM capacity limited to $0.6 million and ELOC capacity of $4.1 million, the company faces significant financing constraints. The stock trades at $0.5891, well below the $1.00 threshold, making a reverse split likely.

At the time of this filing, BFRG was trading at $0.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.5M. The 52-week trading range was $0.43 to $2.04. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BFRG - Latest Insights

BFRG
Jul 06, 2026, 4:00 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.698
Real-time Price: $0.5684 info
Change: -$0.1296 (-19%) info
Market Cap: $10.535M info
BFRG
Jun 15, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6387
Real-time Price: $0.5684 info
Change: -$0.0703 (-11%) info
Market Cap: $10.535M info
BFRG
May 29, 2026, 4:34 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $0.7551
Real-time Price: $0.5684 info
Change: -$0.1867 (-25%) info
Market Cap: $10.535M info
BFRG
May 14, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.602
Real-time Price: $0.5684 info
Change: -$0.0336 (-6%) info
Market Cap: $10.535M info
BFRG
Apr 13, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.01
Real-time Price: $0.5684 info
Change: -$0.4416 (-44%) info
Market Cap: $10.535M info